Literature DB >> 11040132

Influenza A virus neuraminidase: regions of the protein potentially involved in virus-host interactions.

T G Fanning1, A H Reid, J K Taubenberger.   

Abstract

Phylogenetically informative amino acid positions (PIPs) were identified in influenza A neuraminidases of subtypes N1 and N2. Neuraminidase evolves in a lineage-specific way as the virus adapts to a new host or changes to evade the host's immune system. Thus, many PIPs undoubtedly identify positions involved in virus-host interactions. Phylogenetically important regions (PIRs) are defined as several PIPs near one another. There are 15 PIRs on N1 and 12 on N2, seven of which are shared between the two subtypes. Many PIRs are coincident with antigenic or glycosylation sites. Other PIRs may represent additional antigenic sites or may be involved in other aspects of virus-host biology. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11040132     DOI: 10.1006/viro.2000.0578

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  28 in total

1.  Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).

Authors:  Upma Gulati; Chi-Ching Hwang; Lalitha Venkatramani; Shelly Gulati; Stephen J Stray; Janis T Lee; W Graeme Laver; Alexey Bochkarev; Adam Zlotnick; Gillian M Air
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Extrapolating from sequence--the 2009 H1N1 'swine' influenza virus.

Authors:  Venkataramanan Soundararajan; Kannan Tharakaraman; Rahul Raman; S Raguram; Zachary Shriver; V Sasisekharan; Ram Sasisekharan
Journal:  Nat Biotechnol       Date:  2009-06       Impact factor: 54.908

3.  A preliminary panorama of the diversity of N1 subtype influenza viruses.

Authors:  Ji-Ming Chen; Hong-Chao Ma; Ji-Wang Chen; Ying-Xue Sun; Jin-Ming Li; Zhi-Liang Wang
Journal:  Virus Genes       Date:  2006-10-04       Impact factor: 2.332

Review 4.  Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines.

Authors:  Glendie Marcelin; Matthew R Sandbulte; Richard J Webby
Journal:  Rev Med Virol       Date:  2012-03-22       Impact factor: 6.989

5.  Novel origin of the 1918 pandemic influenza virus nucleoprotein gene.

Authors:  Ann H Reid; Thomas G Fanning; Thomas A Janczewski; Raina M Lourens; Jeffery K Taubenberger
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

6.  Genetic and pathobiologic characterization of pandemic H1N1 2009 influenza viruses from a naturally infected swine herd.

Authors:  Hana M Weingartl; Yohannes Berhane; Tamiko Hisanaga; James Neufeld; Helen Kehler; Carissa Emburry-Hyatt; Kathleen Hooper-McGreevy; Samantha Kasloff; Brett Dalman; Jan Bystrom; Soren Alexandersen; Yan Li; John Pasick
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

7.  Adjustment of receptor-binding and neuraminidase substrate specificities in avian-human reassortant influenza viruses.

Authors:  Yulia Shtyrya; Larisa Mochalova; Galina Voznova; Irina Rudneva; Aleksandr Shilov; Nikolai Kaverin; Nicolai Bovin
Journal:  Glycoconj J       Date:  2008-07-26       Impact factor: 2.916

8.  Identification of human H1N2 and human-swine reassortant H1N2 and H1N1 influenza A viruses among pigs in Ontario, Canada (2003 to 2005).

Authors:  Alexander I Karasin; Suzanne Carman; Christopher W Olsen
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

9.  Influenza AH1N2 viruses, United Kingdom, 2001-02 influenza season.

Authors:  Joanna S Ellis; Adriana Alvarez-Aguero; Vicky Gregory; Yi Pu Lin; A Hay; Maria C Zambon
Journal:  Emerg Infect Dis       Date:  2003-03       Impact factor: 6.883

10.  Mapping the sequence mutations of the 2009 H1N1 influenza A virus neuraminidase relative to drug and antibody binding sites.

Authors:  Sebastian Maurer-Stroh; Jianmin Ma; Raphael Tze Chuen Lee; Fernanda L Sirota; Frank Eisenhaber
Journal:  Biol Direct       Date:  2009-05-20       Impact factor: 4.540

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.